APA

Kuivanen S., Bespalov M. M., Nandania J., Ianevski A., Velagapudi V., De Brabander J. K., Kainov D. E. & Vapalahti O. (20171227). Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. : Antiviral research.

Chicago

Kuivanen Suvi, Bespalov Maxim M, Nandania Jatin, Ianevski Aleksandr, Velagapudi Vidya, De Brabander Jef K, Kainov Denis E and Vapalahti Olli. 20171227. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. : Antiviral research.

Harvard

Kuivanen S., Bespalov M. M., Nandania J., Ianevski A., Velagapudi V., De Brabander J. K., Kainov D. E. and Vapalahti O. (20171227). Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. : Antiviral research.

MLA

Kuivanen Suvi, Bespalov Maxim M, Nandania Jatin, Ianevski Aleksandr, Velagapudi Vidya, De Brabander Jef K, Kainov Denis E and Vapalahti Olli. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. : Antiviral research. 20171227.